
Zylox-Tonbridge Medical Technology Co Ltd
HKEX:2190

Zylox-Tonbridge Medical Technology Co Ltd
Total Equity
Zylox-Tonbridge Medical Technology Co Ltd
Total Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Total Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
![]() |
Zylox-Tonbridge Medical Technology Co Ltd
HKEX:2190
|
Total Equity
ÂĄ3.1B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
80%
|
CAGR 10-Years
N/A
|
|
A
|
APT Medical Inc
SSE:688617
|
Total Equity
ÂĄ1.9B
|
CAGR 3-Years
61%
|
CAGR 5-Years
48%
|
CAGR 10-Years
N/A
|
|
J
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
|
Total Equity
ÂĄ12.5B
|
CAGR 3-Years
15%
|
CAGR 5-Years
16%
|
CAGR 10-Years
22%
|
|
![]() |
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
Total Equity
ÂĄ37.1B
|
CAGR 3-Years
13%
|
CAGR 5-Years
16%
|
CAGR 10-Years
N/A
|
|
L
|
Lepu Medical Technology Beijing Co Ltd
SZSE:300003
|
Total Equity
ÂĄ15.8B
|
CAGR 3-Years
10%
|
CAGR 5-Years
16%
|
CAGR 10-Years
18%
|
|
![]() |
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
|
Total Equity
ÂĄ18.9B
|
CAGR 3-Years
74%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Zylox-Tonbridge Medical Technology Co Ltd
Glance View
Zylox-Tonbridge Medical Technology Co., Ltd. operates as a medical devices company. The company is headquartered in Hangzhou, Zhejiang and currently employs 487 full-time employees. The company went IPO on 2021-07-05. The firm's main products include Thrombite Clot Retriever Device (Thrombite CRD) and Ultrafree Drug Coated PTA Balloon Catheter (Ultrafree DCB). The firm's products are sold to domestic and foreign markets.

See Also
What is Zylox-Tonbridge Medical Technology Co Ltd's Total Equity?
Total Equity
3.1B
CNY
Based on the financial report for Dec 31, 2024, Zylox-Tonbridge Medical Technology Co Ltd's Total Equity amounts to 3.1B CNY.
What is Zylox-Tonbridge Medical Technology Co Ltd's Total Equity growth rate?
Total Equity CAGR 5Y
80%
Over the last year, the Total Equity growth was 0%. The average annual Total Equity growth rates for Zylox-Tonbridge Medical Technology Co Ltd have been -1% over the past three years , 80% over the past five years .